Ruud Houben - Department of Radiation Oncology, MAASTRO Clinic, Maastricht, The Netherlands

基本信息

浏览量：129

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 111 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The existence of cranial bone flap displacement during brain radiotherapy

Nikolina E Birimac, Yves C P Willems,Catharina M L Zegers, Femke Vaassen,David Hofstede,Inge Compter,Jaap Jaspers,Alejandra Méndez Romero,Martinus P G Broen,Ans Swinnen, Olaf E M G Schijns,Mirko Unipan,

Technical innovations & patient support in radiation oncology (2024): 100250-100250

引用0浏览0WOS引用

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy

Francesco Cortiula,Lizza E. L. Hendriks,Robin Wijsman,Ruud Houben, Michelle Steens, Sarah Debakker,Richard Canters,Marco Trovo,Nanna M. Sijtsema,Anne G. H. Niezink,Mirko Unipan, Susanna Urban,

RADIOTHERAPY AND ONCOLOGY（2024）

引用0浏览0WOS引用

Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials

Ilinca Popp,Rianne D. W. Vaes,Lotte Wieten,Sonja Adebahr,Lizza Hendriks, Elham Bavafaye Haghighi,Juliette Degens,Henning Scha,Christine Greil,Cornelius F. Waller,Ruud Houben,Gabriele Niedermann,

RADIOTHERAPY AND ONCOLOGY (2024): 110048-110048

引用0浏览0WOS引用

PO-1959 Dosimetric benefits of proton therapy over (non)-coplanar photon radiotherapy in pituitary adenoma

M. Nogarede, A. Swinnen,E. Decabooter, R. Emmah, L. Verheesen, H. Beurskens, D. Hartgerink, L. in 't Ven,R. Houben, E. Roelofs,D.B. Eekers,I. Compter

Radiotherapy and Oncology (2023): S1721-S1722

引用0浏览0引用

Impact of clinical target volume margin reduction in glioblastoma patients treated with concurrent chemoradiation

Dario Di Perri,David Hofstede,Dianne Hartgerink, Karin Terhaag,Ruud Houben,Alida A. Postma,Ann Hoeben,Monique Anten,Linda Ackermans,Inge Compter,Danielle B. P. Eekers

Neuro-Oncology Practice (2023)

引用0浏览0引用

Impact of CTV margin reduction in glioblastoma patients treated with concurrent chemoradiation

Dario Di Perri,David Hofstede,Dianne Hartgerink, Karin Terhaag,Ruud Houben,Alida A. Postma,Ann Hoeben,Monique M. Anten,Linda Ackermans,Inge Compter,Daniëlle Eekers

Neuro-Oncology Practice (2023)

引用0浏览0引用

1298P Chemotherapy with concurrent proton vs. photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and immune therapy

F. Cortiula, L. Hendriks, R. Wijsman,R. Houben, M. Steens, S. Debakker, C. Reverberi, N.M. Sijtsema, A. Niezink, S. Urban, A. Michelotti, S. Dursun,

Annals of Oncology (2023): S748-S749

引用0浏览0引用

MO-0556 Reduction of the CTV margin in glioblastoma leads to dosimetric benefit without compromising outcome

D. Di Perri, D. Hartgerink, K. Terhaag,R. Houben,I. Compter,D. Eekers

Radiotherapy and Oncology (2023): S435-S437

引用0浏览0引用

Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study

Haiyan Zeng,Lizza E L Hendriks,Willem J A Witlox,Harry J M Groen,Anne-Marie C Dingemans,John Praag,José Belderbos,Ruud Houben,Vincent van der Noort,Dirk K M De Ruysscher

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (2023): 109627-109627

引用0浏览0WOS引用

EP14.01-014 Risk Factors for Brain Metastasis in Patients with Small Cell Lung Cancer: A Systematic Review and Meta-analysis

H. Zeng,D. Zheng,W. Witlox,A. Levy,A. Traverso,F.-M.S. Kong,R. Houben,D. De Ruysscher,L. Hendriks

Journal of Thoracic Oncologyno. 9 (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn